Sopa Pictures | Light Rocket | Getty Images shares of Modern fell on Monday as Wall Street munched over new trial results on the personalized cancer vaccine it is developing note. Merck shares were essentially flat. The experimental mRNA vaccine, when combined with Merck’s blockbuster drug Keytruda, reduces the risk of skin cancer-melanoma recurrence by …
Continue reading “Moderna shares fall regardless of promising most cancers vaccine knowledge”